(600566)"Hubei Jumpcan Pharmaceutical Co., Ltd."Announcement on Results of Shareholding Reduction by Certain Senior Executives
Filed with SSE · Stock code 600566 · · 3 pages · Chinese
Summary by 6ix AI
The filing details the shareholding status of executives before the reduction and the results of their planned share sales.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Hubei Jumpcan Pharmaceutical Co., Ltd on 6ix
Story so far
- (600566)"Hubei Jumpcan Pharmaceutical Co., Ltd."Announcement on Self-exercise Results in Q3 2026 under the 2022 Restricted Share and Stock Option Incentive Plan and Changes in Share Capital
- (600566)"Hubei Jumpcan Pharmaceutical Co., Ltd."Announcement on Progress in Repurchasing Shares through Call Auction
- (600566)"Hubei Jumpcan Pharmaceutical Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing
Earlier from Hubei Jumpcan Pharmaceutical
- (600566)"Hubei Jumpcan Pharmaceutical Co., Ltd."Indicative Announcement on Restricted Exercise Period for the Initial Grant of Stock Options under the 2022 Restricted Share and Stock Option Incentive Plan
- (600566)"Hubei Jumpcan Pharmaceutical Co., Ltd."Announcement on Self-exercise Results in Q3 2026 under the 2022 Restricted Share and Stock Option Incentive Plan and Changes in Share Capital
- (600566)"Hubei Jumpcan Pharmaceutical Co., Ltd."Announcement on Progress in Repurchasing Shares through Call Auction
- (600566)"Hubei Jumpcan Pharmaceutical Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Implementation of Self-exercise for the Second Exercise Period of Stock Options of the Initial Grant under the 2022 Restricted Share and Stock Option Incentive Plan
Follow Hubei Jumpcan Pharmaceutical into a list and get an email when it puts out news.
Follow Hubei Jumpcan Pharmaceutical